RE: Huge Potential18 Aug 2025 14:48
Out of interest, Can anyone price the value of a best in class kinase inhibitor with multiple applications and hopefully low toxicity that may also be able to pass the Blood Brain Barrier to treat even further autoimmune conditions. And then you have to value the skill platform and an advancing kinase inhibitors for cancer? What would a buyout be for the whole of the skill platform. Forget 24p the value of the deal would be priced in the billions. Anyone like to give an estimate?